regenbiopharmainc.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://regenbiopharmainc.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | Checkpoint Inhibitors and Cancer Vaccines | Regen BioPharma, |
| Description | Fast Forwarding Checkpoint Regen BioPharma, Inc. is developing CAR-T cells and cancer vaccines using DNA and RNA technologies to target immune |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 199.34.228.143 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
regenbiopharmainc.com Valuation
|
US$23,593,657
Last updated: 2023-04-27 14:43:35
regenbiopharmainc.com has Semrush global rank of 448,608. regenbiopharmainc.com has an estimated worth of US$ 23,593,657, based on its estimated Ads revenue. regenbiopharmainc.com receives approximately 2,722,345 unique visitors each day. Its web server is located in United States, with IP address 199.34.228.143. According to SiteAdvisor, regenbiopharmainc.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$23,593,657 |
| Daily Ads Revenue | US$21,779 |
| Monthly Ads Revenue | US$653,363 |
| Yearly Ads Revenue | US$7,840,354 |
| Daily Unique Visitors | 181,490 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| regenbiopharmainc.com. | A | 7199 | IP: 199.34.228.143 |
| regenbiopharmainc.com. | NS | 14400 | NS Record: dns143.b.register.com. |
| regenbiopharmainc.com. | NS | 14400 | NS Record: dns151.a.register.com. |
| regenbiopharmainc.com. | NS | 14400 | NS Record: dns024.c.register.com. |
| regenbiopharmainc.com. | NS | 14400 | NS Record: dns177.d.register.com. |
| regenbiopharmainc.com. | MX | 14400 | MX Record: 30 aspmx4.googlemail.com. |
| regenbiopharmainc.com. | MX | 14400 | MX Record: 30 aspmx5.googlemail.com. |
| regenbiopharmainc.com. | MX | 14400 | MX Record: 10 aspmx.l.google.com. |
| regenbiopharmainc.com. | MX | 14400 | MX Record: 20 alt1.aspmx.l.google.com. |
| regenbiopharmainc.com. | MX | 14400 | MX Record: 30 aspmx2.googlemail.com. |
| regenbiopharmainc.com. | MX | 14400 | MX Record: 20 alt2.aspmx.l.google.com. |
| regenbiopharmainc.com. | MX | 14400 | MX Record: 30 aspmx3.googlemail.com. |
HtmlToTextCheckTime:2023-04-27 14:43:35
| Menu Menu Fast Forwarding Checkpoint Medicine Striving to improve the quality of life by introducing the latest in medical technology for treating cancer and autoimmunity. Striving to improve the quality of life by introducing the latest in medical technology for treating cancer and autoimmunity. Know more Know more What we do Regen BioPharma Inc. is a publicly traded biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA and DNA-based immunotherapy and small molecules in the immune-oncology and autoimmune disease space. The Company plans to rapidly advance novel technologies through pre-clinical and Phase I/ II clinical trials. Currently, the Company is advancing therapies for treating cancer and autoimmune disorders by modulating the immune checkpoint NR2F6. The company is also developing products treating blood disorders using small molecules and gene silencing (DiffronC), treating cancer with cellular immunotherapy (dCellVax, |
HTTP Headers
HTTP/1.1 301 Moved Permanently Date: Wed, 20 Oct 2021 19:38:35 GMT Server: Apache Location: http://www.regenbiopharmainc.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 301 Moved Permanently Date: Wed, 20 Oct 2021 19:38:36 GMT Server: Apache Set-Cookie: is_mobile=0; path=/; domain=www.regenbiopharmainc.com Vary: X-W-SSL,User-Agent Location: https://www.regenbiopharmainc.com/ X-Host: pages18.sf2p.intern.weebly.net X-UA-Compatible: IE=edge,chrome=1 Content-Length: 382 Content-Type: text/html; charset=UTF-8 HTTP/1.1 200 OK Date: Wed, 20 Oct 2021 19:38:36 GMT Server: Apache Set-Cookie: is_mobile=0; path=/; domain=www.regenbiopharmainc.com Vary: X-W-SSL,Accept-Encoding,User-Agent Set-Cookie: language=en; expires=Wed, 03-Nov-2021 19:38:36 GMT; Max-Age=1209600; path=/ Cache-Control: private ETag: W/"ac59ed252a9b95f4523818c6ddaab54e" X-Host: pages28.sf2p.intern.weebly.net X-UA-Compatible: IE=edge,chrome=1 Content-Type: text/html; charset=UTF-8 |
regenbiopharmainc.com Whois Information
Domain Name: REGENBIOPHARMAINC.COM Registry Domain ID: 1955597901_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2021-08-14T20:25:10Z Creation Date: 2015-08-27T00:14:26Z Registry Expiry Date: 2023-08-27T00:14:26Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.REGISTER.COM Name Server: DNS2.REGISTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-09T10:38:43Z <<< |